A recent study published in Frontiers in Nutrition investigated the effects of a ketogenic diet on patients with glioblastoma multiforme (GBM), an aggressive form of brain cancer. The study observed 18 patients over eight years, from January 2016 to January 2024. Among these, six patients adhered to the ketogenic diet for more than six months. Remarkably, 66.7% of these adherent patients experienced a significant increase in survival rates, compared to just 8.3% among those who did not maintain the diet. The ketogenic diet, characterized by high-fat and low-carbohydrate intake, aims to shift the body’s energy source from glucose to ketones, potentially starving cancer cells that predominantly rely on glucose for energy.
Despite these promising findings, it’s essential to approach the results with caution due to the study’s small sample size and the challenges patients may face in maintaining such a restrictive diet. The ketogenic diet’s efficacy as a complementary treatment for GBM requires further investigation through larger clinical trials to validate these initial observations. Patients considering dietary interventions should consult with their healthcare providers to ensure safety and appropriateness within their overall treatment plan. Click for More Details
